IMA Annual Report 2009

The IMA´s contribution to the work of the EEA Medicines Agencies and the European Medicines Agency increased this year with active participation in numerous expert committees.


In the introduction of the report Rannveig Gunnarsdottir, the executive director of IMA, writes that The Icelandic Medicines Agency has issued more licenses this year than ever before. In 22 Decentralised / Mutual Recognition Marketing Authorisations Iceland acted as a Reference Member State.

The Icelandic Medicines Control Agency decided to shorten its name to The Icelandic Medicines Agency, IMA, in line with what many sister EEA agencies have chosen to do.

IMA Annual Report 2009
Back Send article